803 related articles for article (PubMed ID: 12900505)
21. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics.
Booman M; Douwes J; Glas AM; de Jong D; Schuuring E; Kluin PM
J Pathol; 2006 Oct; 210(2):163-71. PubMed ID: 16823896
[TBL] [Abstract][Full Text] [Related]
22. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
Gormley RP; Madan R; Dulau AE; Xu D; Tamas EF; Bhattacharyya PK; LeValley A; Xue X; Kumar P; Sparano J; Ramesh KH; Pulijaal V; Cannizzaro L; Walsh D; Ioachim HL; Ratech H
Am J Clin Pathol; 2005 Nov; 124(5):790-8. PubMed ID: 16203284
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
Liu YH; Xu FP; Zhuang HG; Lai KC; Xie D; Luo DL; Li L; Luo XL; Xu J; Zhang MH; Zhang F; Li HM
Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
[TBL] [Abstract][Full Text] [Related]
24. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
Yoon SO; Jeon YK; Paik JH; Kim WY; Kim YA; Kim JE; Kim CW
Histopathology; 2008 Aug; 53(2):205-17. PubMed ID: 18752503
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expression.
Miyazaki K; Yamaguchi M; Suguro M; Choi W; Ji Y; Xiao L; Zhang W; Ogawa S; Katayama N; Shiku H; Kobayashi T
Br J Haematol; 2008 Aug; 142(4):562-70. PubMed ID: 18537973
[TBL] [Abstract][Full Text] [Related]
26. Logical analysis of diffuse large B-cell lymphomas.
Alexe G; Alexe S; Axelrod DE; Hammer PL; Weissmann D
Artif Intell Med; 2005 Jul; 34(3):235-67. PubMed ID: 16023562
[TBL] [Abstract][Full Text] [Related]
27. Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics.
Valet GK; Hoeffkes HG
Cytometry A; 2004 Jun; 59(2):232-6. PubMed ID: 15170602
[TBL] [Abstract][Full Text] [Related]
28. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.
Tagawa H; Suguro M; Tsuzuki S; Matsuo K; Karnan S; Ohshima K; Okamoto M; Morishima Y; Nakamura S; Seto M
Blood; 2005 Sep; 106(5):1770-7. PubMed ID: 15886317
[TBL] [Abstract][Full Text] [Related]
29. National Oncology Forum: perspectives for the year 2000.
DeVita VT; Bleickardt EW
Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
[TBL] [Abstract][Full Text] [Related]
30. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
Costa LJ; Feldman AL; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Ansell SM
Br J Haematol; 2008 Jul; 142(3):404-12. PubMed ID: 18492096
[TBL] [Abstract][Full Text] [Related]
31. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
Mircean C; Tabus I; Kobayashi T; Yamaguchi M; Shiku H; Shmulevich I; Zhang W
Int J Oncol; 2004 Mar; 24(3):497-504. PubMed ID: 14767533
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of diffuse large B-cell lymphoma.
Rosenwald A; Staudt LM
Leuk Lymphoma; 2003; 44 Suppl 3():S41-7. PubMed ID: 15202524
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
[TBL] [Abstract][Full Text] [Related]
34. Serotonin receptor 3A expression in normal and neoplastic B cells.
Rinaldi A; Chiaravalli AM; Mian M; Zucca E; Tibiletti MG; Capella C; Bertoni F
Pathobiology; 2010; 77(3):129-35. PubMed ID: 20516728
[TBL] [Abstract][Full Text] [Related]
35. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
36. DNA microarrays in lymphoid malignancies.
Rosenwald A
Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
[TBL] [Abstract][Full Text] [Related]
37. The biology of human lymphoid malignancies revealed by gene expression profiling.
Staudt LM; Dave S
Adv Immunol; 2005; 87():163-208. PubMed ID: 16102574
[TBL] [Abstract][Full Text] [Related]
38. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
Bea S; Zettl A; Wright G; Salaverria I; Jehn P; Moreno V; Burek C; Ott G; Puig X; Yang L; Lopez-Guillermo A; Chan WC; Greiner TC; Weisenburger DD; Armitage JO; Gascoyne RD; Connors JM; Grogan TM; Braziel R; Fisher RI; Smeland EB; Kvaloy S; Holte H; Delabie J; Simon R; Powell J; Wilson WH; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Campo E; Rosenwald A;
Blood; 2005 Nov; 106(9):3183-90. PubMed ID: 16046532
[TBL] [Abstract][Full Text] [Related]
39. DNA microarray data and contextual analysis of correlation graphs.
Rougemont J; Hingamp P
BMC Bioinformatics; 2003 Apr; 4():15. PubMed ID: 12720549
[TBL] [Abstract][Full Text] [Related]
40. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
Davis RE; Brown KD; Siebenlist U; Staudt LM
J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
